ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,350,000 | +4118.8% | 50,660 | +3339.2% | 0.00% | – |
| Q1 2021 | $32,000 | -75.6% | 1,473 | -73.2% | 0.00% | – |
| Q4 2020 | $131,000 | +322.6% | 5,495 | +184.1% | 0.00% | – |
| Q3 2020 | $31,000 | -46.6% | 1,934 | -24.9% | 0.00% | – |
| Q2 2020 | $58,000 | +5700.0% | 2,574 | +4337.9% | 0.00% | – |
| Q1 2020 | $1,000 | -98.0% | 58 | -98.1% | 0.00% | – |
| Q4 2019 | $50,000 | -37.5% | 3,061 | +33.0% | 0.00% | – |
| Q3 2019 | $80,000 | -30.4% | 2,302 | +12.5% | 0.00% | – |
| Q2 2019 | $115,000 | +505.3% | 2,047 | +584.6% | 0.00% | – |
| Q4 2018 | $19,000 | -17.4% | 299 | +30.0% | 0.00% | – |
| Q3 2018 | $23,000 | +130.0% | 230 | +51.3% | 0.00% | – |
| Q2 2018 | $10,000 | +233.3% | 152 | +347.1% | 0.00% | – |
| Q4 2017 | $3,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |